TrialBMC cancer2021

Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301.

Norihito Okumura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.